Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Goodeve

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Thrombosis and Haemostasis|February 1, 1997
HLA class II profile: a weak determinant of factor VIII inhibitor development in severe haemophilia A. UKHCDO Inhibitor Working PartyC R Hay, W Ollier, L Pepper, et al.
Blood|March 9, 2000
Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factorS Allen, A M Abuzenadah, J L Blagg, et al.
British Journal of Haematology|November 25, 2000
FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk groupF M Abu-Duhier, A C Goodeve, G A Wilson, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Thrombosis and Haemostasis|February 1, 1997
HLA class II profile: a weak determinant of factor VIII inhibitor development in severe haemophilia A. UKHCDO Inhibitor Working PartyC R Hay, W Ollier, L Pepper, et al.
Blood|March 9, 2000
Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factorS Allen, A M Abuzenadah, J L Blagg, et al.
British Journal of Haematology|November 25, 2000
FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk groupF M Abu-Duhier, A C Goodeve, G A Wilson, et al.
Pageof 5